Stockscreener 앱 받기
37.21
1.48%
-0.56
시간 외 거래:
37.21
전일 마감가:
$37.77
열려 있는:
$37.6
하루 거래량:
10.24M
Relative Volume:
0.39
시가총액:
$8.47B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
53.93
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
-5.08%
1개월 성능:
-4.64%
6개월 성능:
-34.89%
1년 성능:
+23.66%
1일 변동 폭
$36.85
$38.88
1주일 범위
$36.65
$40.74
52주 변동 폭
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
37.21 | 8.60B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Marex Group plc Invests $53.63 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Q3 Earnings and Regulatory Challenges - Quiver Quantitative
Biomarker Testing Experiences - Trend Hunter
Hims & Hers Expands Weight-Management Program to the United Kingdom - Finviz
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - Yahoo Finance
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? - MSN
Why Novo Nordisk Stock Topped the Market on Thursday - AOL.com
Hims & Hers targets UK’s weight loss market - eMarketer
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Hims & Hers Health's Options: A Look at What the Big Money is Thinking - Benzinga
Insider Sell Alert: Perez Garcia Andrea G Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims stock falls after lawmakers propose GLP-1 compounding restrictions By Investing.com - Investing.com Nigeria
High Short-Interest Stocks to Buy Before Q1 2026 - Investing.com
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? - Finviz
Hims & Hers Health (NYSE:HIMS) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Hims & Hers Expands Weight Loss Program to the U.K. - Yahoo Finance
Hims & Hers (HIMS) Expands Weight Loss Program to the UK - GuruFocus
HIMS Expands Weight Loss Program to the UK - GuruFocus
Hims & Hers brings weight loss program to the U.K. (HIMS:NYSE) - Seeking Alpha
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK - PA Media
Hims & Hers launches weight loss program in UK with Hers platform - StreetInsider
Hims and Hers to offer weight-loss treatments in UK - Reuters
Does The Rally In Hims And Hers Health Still Leave Room For Growth In 2025 - Yahoo Finance
(HIMS) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
What Analysts Think Is Changing the Hims and Hers Story for Long Term Investors - Yahoo Finance
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? - Finviz
Barclays Initiates Coverage on Hims & Hers Health (HIMS) with Ov - GuruFocus
5 High Short-Interest Stocks to Buy Before Q1 2026 - MarketBeat
XTX Topco Ltd Cuts Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Barclays Initiates Hims & Hers Health With Overweight Rating, $48 Price Target - marketscreener.com
Invesco Ltd. Purchases 2,128,587 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers' YourBio Health Acquisition: How They Are About To Revolutionize Blood Testing! - Smartkarma
Barclays Initiates Coverage of HIMS with Positive Outlook - GuruFocus
Andrew Dudum: 100 Most Influential People in Healthcare 2025 - Modern Healthcare
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Pharma company eyes Canada as patents lapse on weight-loss drugs - Benefits and Pensions Monitor
Truist Securities reiterates Hold rating on Hims and Hers stock amid soft Q4 trends - Investing.com UK
Divisadero Street Capital Management LP Sells 646,934 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Why Hims & Hers Stock Slipped Today - AOL.com
Promising Healthcare Stocks To Add to Your WatchlistDecember 7th - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Telehealth Trends - Quiver Quantitative
Jump Financial LLC Sells 155,479 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers: The Market's Panic Is Irrational (NYSE:HIMS) - Seeking Alpha
Arrowstreet Capital Limited Partnership Has $28.36 Million Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Stake Lowered by State Board of Administration of Florida Retirement System - MarketBeat
Clear Street LLC Invests $83.58 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Remin - The National Law Review
HIMS HERS HEALTH INC - Financial Post
Hims and Hers acquires Livewell ahead of generic Ozempic launch in Canada - Financial Post
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves - TradingView
Hims & Hers Continues Major International Expansion With Officia - GuruFocus
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.50%
자본화:
|
볼륨(24시간):